Effect of Ritonavir on 99m Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs-Reference-Cited by-同舟云学术

Effect of Ritonavir on 99m Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs

Published:2013-01 Issue:1 Volume:2 Page:20
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT: Pharmacometrics & Systems Pharmacology

Author:

Pfeifer ND¹,Goss SL¹,Swift B¹,Ghibellini G¹,Ivanovic M²,Heizer WD³,Gangarosa LM³,Brouwer KLR¹

Affiliation:

1. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA

2. Department of Radiology; University of North Carolina Hospital; Chapel Hill North Carolina USA

3. Department of Medicine; University of North Carolina School of Medicine; Chapel Hill North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/psp.2012.21/fullpdf

Reference50 articles.

1. US Food and Drug Administration Draft Guidance for Industry: Drug Interaction Studies, Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations US Department of Health and Human Services, FDA, Center for Drug Use and Evaluation (CDER) Silver Spring, MD 2012

2. European Medical Agency Guideline on the Investigation of Drug Interactions Committee for Human Medicinal Products (CHMP) London, UK 2012

3. The role of hepatic transporters in drug elimination;Funk;Expert Opin. Drug Metab. Toxicol.,2008

4. Hepatobiliary transporters and drug-induced cholestasis;Pauli-Magnus;Hepatology,2006

5. Visualization of multidrug resistance in vivo;Hendrikse;Eur. J. Nucl. Med.,1999

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Membrane transporters in drug development and as determinants of precision medicine;Nature Reviews Drug Discovery;2024-01-24

2. Physiologically based radiopharmacokinetic (PBRPK) modeling to simulate and analyze radiopharmaceutical therapies: studies of non-linearities, multi-bolus injections, and albumin binding;EJNMMI Radiopharmacy and Chemistry;2024-01-22

3. The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023;Drug Metabolism and Disposition;2023-07-05

4. Use of In Vivo Imaging and Physiologically-Based Kinetic Modelling to Predict Hepatic Transporter Mediated Drug–Drug Interactions in Rats;Pharmaceutics;2023-03-10

5. Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients;Acta Pharmaceutica Sinica B;2023-01